tenk.fyi

Terns Pharmaceuticals, Inc.

TERNNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$96.2M

8.3% YoY

EPS

$-1.03

8.0% YoY

Cash

$524.7M

225.0% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro